Skip to main content
Clinical Trials/NCT06176703
NCT06176703
Recruiting
N/A

Mobile Application for Self-Management of Type 2 Diabetes Mellitus: Randomized Controlled Trial

Ramathibodi Hospital1 site in 1 country128 target enrollmentNovember 22, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Diabetes Mellitus, Type 2
Sponsor
Ramathibodi Hospital
Enrollment
128
Locations
1
Primary Endpoint
Glycemic control
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The goal of this Randomized Controlled Trial is to study the effect of mobile Application on glycemic control of type2 diabetes mellitus. The main questions aim to answer are:

  • The effect of mobile application on glycemic control and quality of life of diabetes mellitus patients
  • The satisfaction of mobile application of diabetes mellitus patients who used it Participants will be received education about diabetes mellitus and separated into two groups, intervention group(using mobile application) and control group(not using mobile application but also receive standard treatment of diabetes mellitus.

Researchers will compare intervention group to control group about glycemic control including HbA1c, complications of diabetes mellitus etc. and quality of life.

Registry
clinicaltrials.gov
Start Date
November 22, 2023
End Date
November 22, 2025
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Supasuta Wongdama

Principal Investigator

Ramathibodi Hospital

Eligibility Criteria

Inclusion Criteria

  • Type2 diabetes mellitus who have HbA1c above 7%
  • Can use application on smartphone
  • age 18 years old or more (relatives are accept if participants have age more than 65 years old and cannot use smartphone)
  • consent to participate the research

Exclusion Criteria

  • refuse to participate the research
  • pregnancy
  • using continuous glucose monitoring system or insulin pump
  • disability in sight or hearing
  • have been using the mobile application(RAMAdiabetes) in the past

Outcomes

Primary Outcomes

Glycemic control

Time Frame: 3-6 months

Fasting blood sugar

Secondary Outcomes

  • self-diabetes management(3-6 months)
  • Quality of life(3-6 months)

Study Sites (1)

Loading locations...

Similar Trials